On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
We note that PHARMAC reported in June 2017 that the special $3.2 million fund they set up in 2007 to fund the SOLD Herceptin trial to...
Women with breast cancer, their family, whanau and supporters are marching to Parliament on 16 October to present petitions to MPs – calling for the funding of breakthrough advanced breast cancer medicines Ibrance and Kadcyla.
Breast Cancer Aotearoa Coalition media release, 7 September 2018
New Zealand needs to stop treating people with advanced breast cancer as second class citizens, Breast Cancer Aotearoa Coalition (BCAC) says.
The coalition of more than 30 breast cancer-related group says a report out today by the Breast Cancer Foundation of New Zealand (BCFNZ) reveals the shockingly high mortality rates for New Zealand women compared to other comparable countries.
The Government must increase funding for medicines desperately needed by people with breast cancer and other cancers, Breast Cancer Aotearoa Coalition (BCAC) says.
Watch this powerful video of people with breast cancer explaining why they desperately need access to medicines that are currently unfunded in NZ - to stay alive and get more time with their families: Click here to watch: What price do you put on life?
A wealth of knowledge has been brought back to New Zealand by two Breast Cancer Aotearoa Coalition representatives following the Breast Cancer Trials Australia New Zealand annual scientific meeting in Australia.
Committee members Louise Malone and Fay Sowerby attended to gather the latest intelligence to contribute to BCAC’s work supporting, informing and representing women with breast cancer.
Recent international developments in breast cancer medicine approvals emphasise the need for a much broader range of medicines in New Zealand. Availability, combined with funding, would enable oncologists to choose the best medicines and combinations for individual patients, Breast Cancer Aotearoa Coalition (BCAC) says.
Breast Cancer Aotearoa Coalition and Breast Cancer Foundation NZ have made a strongly worded and evidence-based joint submission to PHARMAC requesting that funding for Perjeta (pertuzumab) be extended to all people with HER2-positive advanced breast cancer.
Representatives of Breast Cancer Aotearoa Coalition (BCAC) went to Wellington recently to meet with Government and National MPs who have health responsibilities to discuss some of the key issues affecting those with breast cancer.
The two key issues highlighted by BCAC in the talks were the need to improve access to medicines; and the need to address inequities for Māori and Pasifika women in breast cancer screening and treatment.
Important research released 21 June shows huge disparities in breast cancer screening, treatment and outcomes for Māori and Pasifika women in New Zealand.
The Breast Cancer Aotearoa Coalition (BCAC) says this is unacceptable and is calling for significant immediate steps to be taken to improve this situation.